A company specializing in cannabis-based medications has developed two new medications for the treatment of fibromyalgia pain and diabetic nerve pain. A transdermal patch is placed on the skin and bloodstream for the medication of fibromyalgia pain and diabetic nerve pain.
The patches promote healing of an injured area of the body. In comparison with other types of medication administration such as oral, topical, intravenous, intramuscular, etc., the flight route of transdermal drug administration is more advantageous.
The patch used for the treatment of diabetic nerve pain provides the patient with a controlled release of the medication in the patient, which can be provided to the patient through various forms, such as:
Through a porous membrane that covers a medication reservoir.
Body heat that melts thin layers of medication embedded in the adhesive that will contain the high potency cannabinoid extract (CBD), this extract slowly enters the bloodstream and then penetrates the patient’s central nervous system, providing relief from the pain sought .
The executive director of cannabis science, Mr. Raymond C. Dabney, believes that the future of cannabis science is based on the development of these two new applications of pharmaceutical drugs. The company strives to improve the capacity of the land for growth and facilities to manufacture its own products to supply scientists with patented materials to make these formulations. On the other hand, the cannabis company is also busy investigating more possible medical application needs of cannabis and introducing the methods for supplying these medications.
It is estimated that fibromyalgia affects 2% -8% of the population, while women are approximately twice as likely to suffer from fibromyalgia. People with diabetic nerve pain and fibromyalgia experience generalized chronic pain and alarming pressure response pain. Peripheral neuropathy (PN) is considered a damage or disease that affects the nerves that can affect the function of sensation, movement, glands or organs or other aspects of health, depending on the type of nerves affected.
“CBD is the second important cannabinoid in marijuana after THC. Without the psychoactive effects that THC brings, it has anti-inflammatory and pain relieving properties. Mr. Dabney also concludes that: “in Cannabis Science, most of the national legislation for the legalization of cannabis and cannabis-derived drugs focuses on the development of pharmaceuticals and pharmaceutical applications to meet the enormous and growing demand that is wait for the future ”. few years.”